Search Results - "Vignesh, T"

Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial by Passarelli, Rachel, Ghodoussipour, Saum, Packiam, Vignesh T

Get full text

Soft Computing Techniques for Land Use and Land Cover Monitoring with Multispectral Remote Sensing Images: A Review by Thyagharajan, K. K., Vignesh, T.

“…Multispectral remote sensing images are the primary source in the land use and land cover (LULC) monitoring. This is achieved by LULC classification and LULC…”
Get full text

Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer? by Packiam, Vignesh T., Bhindi, Bimal

Get full text

Electrochemical biosensor for methyl parathion based on single-walled carbon nanotube/glutaraldehyde crosslinked acetylcholinesterase-wrapped bovine serum albumin nanocomposites by Kumar, T.H. Vignesh, Sundramoorthy, Ashok K.

“…Semiconducting single-walled carbon nanotubes (s-SWCNTs) have been demonstrated as an excellent material for transistors, miniaturized devices and sensors due…”
Get full text

Non–muscle‐invasive bladder cancer: Intravesical treatments beyond Bacille Calmette‐Guérin by Packiam, Vignesh T., Johnson, Scott C., Steinberg, Gary D.

“…An unmet need exists for patients with high‐risk non–muscle‐invasive bladder cancer for whom bacille Calmette‐Guérin (BCG) has failed and who seek further…”
Get full text

Block chain espoused adaptive multi-scale dual attention network with quaternion fractional order meixner moments encryption for cyber security in wireless communication network by Soundararajan, S., Nithya, B., Nithya, N., Vignesh, T.

“…Autonomous driving like subsequent generation cyber-physical system (CPS) with present improvement of wireless communication network, here is a substantial…”
Get full text

Consumer Product Recommendation System Using Adapted PSO With Federated Learning Method by Devarajan, Ganesh Gopal, Nagarajan, Senthil Murugan, Daniel, A., Vignesh, T., Kaluri, Rajesh

“…In this paper, we proposed adapted particle swarm optimization integrated federated learning-based sentiment analysis integrated deep learning (aPSO-FLSADL)…”
Get full text

Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. Eur Urol. 2022;82:602–10 by Steinberg, Ryan L., O'Donnell, Michael A., Packiam, Vignesh T.

Get full text

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer by McElree, Ian M., Steinberg, Ryan L., Martin, Alex C., Richards, Jordan, Mott, Sarah L., Gellhaus, Paul T., Nepple, Kenneth G., O'Donnell, Michael A., Packiam, Vignesh T.

“…PURPOSEBacillus Calmette-Guérin (BCG) is currently recommended as adjuvant therapy following complete transurethral resection of bladder tumor for high-risk…”
Get full text

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results by Packiam, Vignesh T., Lamm, Donald L., Barocas, Daniel A., Trainer, Andrew, Fand, Benjamin, Davis, Ronald L., Clark, William, Kroeger, Michael, Dumbadze, Igor, Chamie, Karim, Kader, A. Karim, Curran, Dominic, Gutheil, John, Kuan, Arthur, Yeung, Alex W., Steinberg, Gary D.

“…CG0070 is a replication-competent oncolytic adenovirus that targets bladder tumor cells through their defective retinoblastoma pathway. Prior reports of…”
Get full text

Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime? by Lichtbroun, Benjamin, Ghodoussipour, Saum, Packiam, Vignesh T

Get full text

Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer by McElree, Ian M., Mott, Sarah L., O'Donnell, Michael A., Packiam, Vignesh T.

Get full text

Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis by Williams, Stephen B., Cumberbatch, Marcus G.K., Kamat, Ashish M., Jubber, Ibrahim, Kerr, Preston S., McGrath, John S., Djaladat, Hooman, Collins, Justin W., Packiam, Vignesh T., Steinberg, Gary D., Lee, Eugene, Kassouf, Wassim, Black, Peter C., Cerantola, Yannick, Catto, James W.F., Daneshmand, Siamak

“…Enhanced Recovery After Surgery (ERAS) is a perioperative approach to managing surgical patients. The impact of ERAS on radical cystectomy (RC) outcomes…”
Get full text

Contemporary Treatment of NMIBC-Is It Time to Move on from BCG? by Passarelli, Rachel, Packiam, Vignesh T

“…Non-muscle-invasive bladder cancer (NMIBC) encompasses approximately three-quarters of all bladder cancer (BC) diagnoses. Intravesical Bacillus Calmette-Guerin…”
Get full text

Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is Now by Steinberg, Ryan L, O'Donnell, Michael A, Packiam, Vignesh T

Get full text

Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer by Abou Chakra, Mohamad, Packiam, Vignesh T, O'Donnell, Michael A

“…Failure, intolerance, or shortage of bacillus Calmette-Guerin (BCG) treatment for patients with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) leave…”
Get more information

Natural course of non-center-involving diabetic macular edema progression in patients under initial observation by Pradhana, Divya, Priya, N Swathi, Manayath, George J, Kulkarni, Sucheta, Behera, Umesh C, Agarwal, Tushar, Agarwal, Manisha, Shah, Shalin, A, Giridhar, Surya, Janani, Ramasamy, Kim, Vignesh, T P, Shoba, Sivaprasad, Bhende, Muna, Raman, Rajiv

“…We aim to report the natural course of non-center involving diabetic macular edema (NCIDME) progression to center involving diabetic macular edema (CIDME) and…”
Get full text

Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival? by Packiam, Vignesh T

Get full text

Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage by Packiam, Vignesh T., Werntz, Ryan P., Steinberg, Gary D.

“…Purpose of Review BCG is the gold standard agent used in high-risk non-muscle-invasive bladder cancer (NMIBC) that is amenable to bladder sparing management…”
Get full text

Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer by Chevuru, Phani T., McElree, Ian M., Mott, Sarah L., Steinberg, Ryan L., O'Donnell, Michael A., Packiam, Vignesh T.

“…•Long-term outcomes of Gemcitabine/Docetaxel after BCG-failure are not well described.•We retrospectively assessed 97 patients with median follow-up of 49…”
Get full text